You are here
Home » Tags » thiazolidinediones (TZDs)
thiazolidinediones (TZDs)
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Inzucchi, Silvio E; Bergenstal, Richard M; Buse, John B; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L; Tsapas, Apostolos; Wender, Richard; Matthews, David R
Diabetes care; 2012 Jun;35(6):1364-79. PMID: 22517736
Category:
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
Rodbard, Helena W; Jellinger, Paul S; Davidson, Jaime A; Einhorn, Daniel; Garber, Alan J; Grunberger, George; Handelsman, Yehuda; Horton, Edward S; Lebovitz, Harold; Levy, Philip; Moghissi, Etie S; Schwartz, Stanley S
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; 15(6):540-59. PMID: 19858063
Category:
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan, David M; Buse, John B; Davidson, Mayer B; Ferrannini, Ele; Holman, Rury R; Sherwin, Robert; Zinman, Bernard
Diabetes care; 2009 Jan;32(1):193-203. PMID: 18945920
Category:
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan, David M; Buse, John B; Davidson, Mayer B; Heine, Robert J; Holman, Rury R; Sherwin, Robert; Zinman, Bernard
Diabetes care; 2006 Aug;29(8):1963-72. PMID: 16873813
Category:
The Good, The Bad, and the Ugly Part I: Why I’m not a Fan of the ADA/EASD’s 2012 Position Statement
Posted May 30, 2012 by John L. Leahy, MDTags:
The highly awaited ADA/EASD statement on management of type 2 diabetes was published online April 19th, 2012.1 I feel like a curmudgeon,but as a general statement, I’m not a fan. In fact, I’m worried that at best it will have little impact, and at worst could be harmful.
Beta Cell Failure: A Slippery Slope
Posted March 28, 2012 by John L. Leahy, MDTags:
In the past decade or so, our attempts to define the "earliest” events in Type 2 diabetes (T2DM) have moved increasingly earlier. We’re considering even the years before what we now consider to be the “pre-diabetes” stage—that is, years considerably before there are any clinical signs or symptoms of disease.
How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.
Grant, Richard W; Wexler, Deborah J; Watson, Alice J; Lester, William T; Cagliero, Enrico; Campbell, Eric G; Nathan, David M
Diabetes care; 2007 Jun;30(6):1448-53. PMID: 17337497
Category:
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
Desai, Nihar R; Shrank, William H; Fischer, Michael A; Avorn, Jerry; Liberman, Joshua N; Schneeweiss, Sebastian; Pakes, Juliana; Brennan, Troyen A; Choudhry, Niteesh K
The American journal of medicine; 2012 Mar;125(3):302.e1-7. PMID: 22340932
Category:
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
Rodbard, Helena W; Jellinger, Paul S; Davidson, Jaime A; Einhorn, Daniel; Garber, Alan J; Grunberger, George; Handelsman, Yehuda; Horton, Edward S; Lebovitz, Harold; Levy, Philip; Moghissi, Etie S; Schwartz, Stanley S
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; 15(6):540-59. PMID: 19858063
Category: